Yichang HEC Changjiang Pharmaceutical Co. Ltd. a PRC pharmaceutical manufacturing company that focuses on the development, manufacturing and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company is headquartered in Yichang, Guangdong and currently employs 4,861 full-time employees. The firm's main products include Kewei (Oseltamivir Phosphate Capsules and Granules), Ertongshu (Benzbromarone Tablets), Oumeining (Telmisartan Tablets), Linluoxing (Moxifloxacin Hydrochloride Tablets) and Olmesartan Tablets and other products. The firm is also engaged in the centralized procurement business. The firm mainly conducts its business in the domestic market.
YiChang HEC ChangJiang Pharmaceutical Co Ltd Informations sur les dividendes
YiChang HEC ChangJiang Pharmaceutical Co Ltd a un dividende annuel de 0.00 par action, avec un rendement de 0.00%. Le dividende est payé autre/inconnu et la dernière date d'ex-dividende était le Jul 31, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.00
Jul 31, 2025
Fréquence des paiements
Taux de distribution
Autre/Inconnu
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Jul 31, 2025
$1.50
Aug 1, 2025
Oct 31, 2025
Sep 29, 2020
$0.1136
Sep 30, 2020
Nov 16, 2020
Jun 9, 2020
$0.164
Jun 10, 2020
Jul 10, 2020
Oct 15, 2019
$0.5544
Oct 16, 2019
Nov 15, 2019
Jun 11, 2019
$0.3415
Jun 12, 2019
Jul 19, 2019
Graphiques des dividendes
YIHCF Dividendes
YIHCF Croissance des dividendes (variation annuelle)